BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18086506)

  • 1. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
    Allard JP; Aghdassi E; Mohammed S; Raman M; Avand G; Arendt BM; Jalali P; Kandasamy T; Prayitno N; Sherman M; Guindi M; Ma DW; Heathcote JE
    J Hepatol; 2008 Feb; 48(2):300-7. PubMed ID: 18086506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
    Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
    Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.
    Elizondo A; Araya J; Rodrigo R; Signorini C; Sgherri C; Comporti M; Poniachik J; Videla LA
    Biol Res; 2008; 41(1):59-68. PubMed ID: 18769764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
    Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C
    Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
    Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.
    Arendt BM; Mohammed SS; Ma DW; Aghdassi E; Salit IE; Wong DK; Guindi M; Sherman M; Heathcote EJ; Allard JP
    Curr HIV Res; 2011 Mar; 9(2):128-35. PubMed ID: 21434863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes.
    Petit JM; Guiu B; Duvillard L; Jooste V; Brindisi MC; Athias A; Bouillet B; Habchi M; Cottet V; Gambert P; Hillon P; Cercueil JP; Verges B
    Clin Nutr; 2012 Aug; 31(4):520-5. PubMed ID: 22209679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
    Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
    J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
    Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
    Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients.
    Elizondo A; Araya J; Rodrigo R; Poniachik J; Csendes A; Maluenda F; Díaz JC; Signorini C; Sgherri C; Comporti M; Videla LA
    Obesity (Silver Spring); 2007 Jan; 15(1):24-31. PubMed ID: 17228028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
    Da Silva HE; Arendt BM; Noureldin SA; Therapondos G; Guindi M; Allard JP
    J Acad Nutr Diet; 2014 Aug; 114(8):1181-94. PubMed ID: 24631112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
    Chalasani N; Deeg MA; Crabb DW
    Am J Gastroenterol; 2004 Aug; 99(8):1497-502. PubMed ID: 15307867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year tracking of fatty acid composition of plasma phospholipids in healthy children.
    Guerra A; Demmelmair H; Toschke AM; Koletzko B
    Ann Nutr Metab; 2007; 51(5):433-8. PubMed ID: 18025816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid composition and development of hepatic lipidosis during food deprivation--mustelids as a potential animal model for liver steatosis.
    Nieminen P; Mustonen AM; Kärjä V; Asikainen J; Rouvinen-Watt K
    Exp Biol Med (Maywood); 2009 Mar; 234(3):278-86. PubMed ID: 19144866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.
    Kang H; Greenson JK; Omo JT; Chao C; Peterman D; Anderson L; Foess-Wood L; Sherbondy MA; Conjeevaram HS
    Am J Gastroenterol; 2006 Oct; 101(10):2247-53. PubMed ID: 17032189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.
    Arendt BM; Comelli EM; Ma DW; Lou W; Teterina A; Kim T; Fung SK; Wong DK; McGilvray I; Fischer SE; Allard JP
    Hepatology; 2015 May; 61(5):1565-78. PubMed ID: 25581263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How different is the dietary pattern in non-alcoholic steatohepatitis patients?
    Cortez-Pinto H; Jesus L; Barros H; Lopes C; Moura MC; Camilo ME
    Clin Nutr; 2006 Oct; 25(5):816-23. PubMed ID: 16677739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood oxidative stress markers are unreliable markers of hepatic steatosis.
    Bonnefont-Rousselot D; Ratziu V; Giral P; Charlotte F; Beucler I; Poynard T;
    Aliment Pharmacol Ther; 2006 Jan; 23(1):91-8. PubMed ID: 16393285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary habits and nutrient intake in non-alcoholic steatohepatitis.
    Toshimitsu K; Matsuura B; Ohkubo I; Niiya T; Furukawa S; Hiasa Y; Kawamura M; Ebihara K; Onji M
    Nutrition; 2007 Jan; 23(1):46-52. PubMed ID: 17140767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.